Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods

Abstract In this study, the minimal residual disease (MRD) levels in patients with multiple myeloma (MM) were assessed by comparing the new 8-color single-tube multiparameter flow cytometry method (DuraClone), which reduces the cost of antibodies and labor burden of laboratories, with the EuroFlow n...

Full description

Saved in:
Bibliographic Details
Main Authors: Takeshi Yoroidaka, Kentaro Narita, Hiroyuki Takamatsu, Momoko Fujisawa, Shinji Nakao, Kosei Matsue
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/0183caa16ebe49ea857003f9cf702b0b
Tags: Add Tag
No Tags, Be the first to tag this record!